Clover Health (CLOV) CEO Jamie L. Reynoso Sells Shares

What Happened
Jamie L. Reynoso, CEO (Medicare Advantage) of Clover Health Investments, sold 7,289 shares of CLOV in an open‑market transaction on June 11, 2026. The weighted average sale price was $4.91 per share for a total proceeds of about $35,789. The filing reports the transaction as a sale (code S).

Key Details

• Transaction date: 2026-06-11 (filed same day; appears timely)
• Shares sold: 7,289; weighted average price: $4.91; total proceeds ≈ $35,789
• Price range: shares were sold in multiple trades at prices between $4.79 and $5.15 (footnote)
• Plan: Sales were made under a pre-established Rule 10b5-1 trading plan adopted March 12, 2026 (footnote)
• Shares owned after transaction: not disclosed in this Form 4

Context
A 10b5-1 plan allows insiders to sell stock according to a pre-set plan and is commonly used to avoid accusations of trading on material nonpublic information; it does not necessarily indicate a change in the insider’s view of the company. This was a routine open‑market sale, not an exercise, grant, or gift.